Transfusion Medicine Reviews
Volume 23, Issue 4 , Pages 266-283 , October 2009

The Role of Neutrophils in the Pathogenesis of Transfusion-Related Acute Lung Injury

  • Yoke Lin Fung

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Lin Fung, Research and Development, Australian Red Cross Blood Service, PO Box 145, Kelvin Grove, QLD 4059, Australia.
    • ,
  • Christopher C. Silliman

References 

  1. Peters AM. Just how big is the pulmonary granulocyte pool?. Clin Sci (Lond). 1998;94:7–19
  2. Ussov WY, Peters AM, Savill J, et al. Relationship between granulocyte activation, pulmonary granulocyte kinetics and alveolar permeability in extrapulmonary inflammatory disease. Clin Sci (Lond). 1996;91:329–335
  3. Chilvers ER, Cadwallader KA, Reed BJ, et al. The function and fate of neutrophils at the inflamed site: Prospects for therapeutic intervention. J R Coll Physicians Lond. 2000;34:68–74
  4. Swain SD, Rohn TT, Quinn MT. Neutrophil priming in host defense: Role of oxidants as priming agents. Antioxid Redox Signal. 2002;4:69–83
  5. Lien DC, Henson PM, Capen RL, et al. Neutrophil kinetics in the pulmonary microcirculation during acute inflammation. Lab Invest. 1991;65:145–159
  6. Doerschuk CM. Neutrophil rheology and transit through capillaries and sinusoids. Am J Respir Crit Care Med. 1999;159:1693–1695
  7. Lee WL, Downey GP. Neutrophil activation and acute lung injury. Curr Opin Crit Care. 2001;7:1–7
  8. Doerschuk CM. Mechanisms of leukocyte sequestration in inflamed lungs. Microcirculation. 2001;8:71–88
  9. Doerschuk CM, Beyers N, Coxson HO, et al. Comparison of neutrophil and capillary diameters and their relation to neutrophil sequestration in the lung. J Appl Physiol. 1993;74:3040–3045
  10. Huang Y, Doerschuk CM, Kamm RD. Computational modeling of RBC and neutrophil transit through the pulmonary capillaries. J Appl Physiol. 2001;90:545–564
  11. Kubo H, Doyle NA, Graham L, et al. L- and P-selectin and CD11/CD18 in intracapillary neutrophil sequestration in rabbit lungs. Am J Respir Crit Care Med. 1999;159:267–274
  12. Doerschuk CM, Tasaka S, Wang Q. CD11/CD18-dependent and -independent neutrophil emigration in the lungs. Am J Respir Cell Mol Biol. 2000;23:133–136
  13. Hallett MB, Lloyds D. Neutrophil priming: The cellular signals that say “amber” but not “green”. Immunol Today. 1995;16:264–268
  14. Sheppard FR, Kelher MR, Moore EE, et al. Structural organization of the neutrophil NADPH oxidase: Phosphorylation and translocation during priming and activation. J Leukoc Biol. 2005;78:1025–1042
  15. Wyman TH, Bjornsen AJ, Elzi DJ, et al. A two-insult in-vitro model of PMN-mediated pulmonary endothelial damage: Requirements for adherence and chemokine release. Am J Physiol Cell Physiol. 2002;283:C1592–C1603
  16. Silliman CC, Ambruso DR, Boshkov LK. Transfusion-related acute lung injury. Blood. 2005;105:2266–2273
  17. Botha AJ, Moore FA, Moore EE, et al. Early neutrophil sequestration after injury: A pathogenic mechanism for multiple organ failure. J Trauma. 1995;39:411–417
  18. Silliman CC, Voelkel NF, Allard JD, et al. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest. 1998;101:1458–1467
  19. Condliffe AM, Kitchen E, Chilvers ER. Neutrophil priming: Pathophysiological consequences and underlying mechanisms. Clin Sci (Lond). 1998;94:461–471
  20. Downey GP, Doherty DE, Schwab B, et al. Retention of leukocytes in capillaries: Role of cell size and deformability. J Appl Physiol. 1990;69:1767–1778
  21. Biffl WL, Moore EE, Zallen G, et al. Neutrophils are primed for cytotoxicity and resist apoptosis in injured patients at risk for multiple organ failure. Surgery. 1999;126:198–202
  22. Murray J, Barbara JA, Dunkley SA, et al. Regulation of neutrophil apoptosis by tumor necrosis factor-alpha: Requirement for TNFR55 and TNFR75 for induction of apoptosis in-vitro. Blood. 1997;90:2772–2783
  23. Kitchen E, Rossi AG, Condliffe AM, et al. Demonstration of reversible priming of human neutrophils using platelet-activating factor. Blood. 1996;88:4330–4337
  24. Karlsson A, Dahlgren C. Assembly and activation of the neutrophil NADPH oxidase in granule membranes. Antioxid Redox Signal. 2002;4:49–60
  25. Lavigne LM, Albina JE, Reichner JS. Beta-glucan is a fungal determinant for adhesion-dependent human neutrophil functions. J Immunol. 2006;177:8667–8675
  26. Popovsky MA, Abel MD, Moore SB. Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. Am Rev Respir Dis. 1983;128:185–189
  27. Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion. 1985;25:573–577
  28. Bernard GR, Artigas A, Brigham KL, et al. Report of the American-European Consensus conference on acute respiratory distress syndrome: Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Consensus Committee. J Crit Care. 1994;9:72–81
  29. Fung YL, Goodison KA, Wong JK, et al. Investigating transfusion-related acute lung injury (TRALI). Intern Med J. 2003;33:286–290
  30. Holness L, Knippen MA, Simmons L, et al. Fatalities caused by TRALI. Transfus Med Rev. 2004;18:184–188
  31. Middelburg RA, van Stein D, Briet E, et al. The role of donor antibodies in the pathogenesis of transfusion-related acute lung injury: A systematic review. Transfusion. 2008;48:2167–2176
  32. Reil A, Keller-Stanislawski B, Gunay S, et al. Specificities of leukocyte alloantibodies in transfusion-related acute lung injury and results of leukocyte antibody screening of blood donors. Vox Sang. 2008;95:313–317
  33. McCullough J, Weiblen BJ, Clay ME, et al. Effect of leukocyte antibodies on the fate in-vivo of indium-111–labeled granulocytes. Blood. 1981;58:164–170
  34. Dutcher JP, Schiffer CA, Johnston GS, et al. Alloimmunization prevents the migration of transfused indium-111–labeled granulocytes to sites of infection. Blood. 1983;62:354–360
  35. McCullough J, Clay M, Hurd D, et al. Effect of leukocyte antibodies and HLA matching on the intravascular recovery, survival, and tissue localization of 111-indium granulocytes. Blood. 1986;67:522–528
  36. Dutcher JP, Riggs CJ, Fox JJ, et al. Effect of histocompatibility factors on pulmonary retention of indium-111–labeled granulocytes. Am J Hematol. 1990;33:238–243
  37. Seeger W, Schneider U, Kreudler B, et al. Reproduction of transfusion-related acute lung injury in an ex-vivo lung model. Blood. 1990;76:1438–1444
  38. Sachs UJ, Hattar K, Weissmann N, et al. Antibody-induced neutrophil activation as a trigger for transfusion-related acute lung injury in an ex-vivo rat lung model. Blood. 2006;107:1217–1219
  39. Brittingham TE. Immunologic studies on leukocytes. Vox Sang. 1957;2:242–248
  40. Kleinman S, Caulfield T, Chan P, et al. Toward an understanding of transfusion-related acute lung injury: Statement of a consensus panel. Transfusion. 2004;44:1774–1789
  41. Dooren MC, Ouwehand WH, Verhoeven AJ, et al. Adult respiratory distress syndrome after experimental intravenous gamma-globulin concentrate and monocyte-reactive IgG antibodies. Lancet. 1998;352:1601–1602
  42. Looney MR, Su X, Van Ziffle JA, et al. Neutrophils and their Fc gamma receptors are essential in a mouse model of transfusion-related acute lung injury. J Clin Invest. 2006;116:1615–1623
  43. Dykes A, Smallwood D, Kotsimbos T, et al. Transfusion-related acute lung injury (TRALI) in a patient with a single lung transplant. Br J Haematol. 2000;109:674–676
  44. Popovsky MA. Transfusion-related acute lung injury (TRALI). In:  Popovsky MA editors. Transfusion Reactions. Bethesda: AABB Press; 2001;p. 155–170
  45. Bux J. Transfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusion. Vox Sang. 2005;89:1–10
  46. Kopko PM, Paglieroni TG, Popovsky MA, et al. TRALI: Correlation of antigen-antibody and monocyte activation in donor-recipient pairs. Transfusion. 2003;43:177–184
  47. Win N, Brown C, Navarrete C. TRALI associated with HLA class II antibodies. Transfusion. 2003;43:545–546
  48. Lydaki E, Bolonaki E, Nikoloudi E, et al. HLA class II antibodies in transfusion-related acute lung injury (TRALI). A case report. Transfus Apher Sci. 2005;33:107–111
  49. Zarco MA, Ribera JM, Urbano-Ispizua A, et al. Phenotypic changes in neutrophil granulocytes of healthy donors after G-CSF administration. Haematologica. 1999;84:874–878
  50. Spagnoli GC, Juretic A, Rosso R, et al. Expression of HLA-DR in granulocytes of polytraumatized patients treated with recombinant human granulocyte macrophage-colony-stimulating factor. Hum Immunol. 1995;4:45–50
  51. Nishimura M, Mitsunaga S, Ishikawa Y, et al. Possible mechanisms underlying development of transfusion-related acute lung injury: Roles of anti-major histocompatibility complex class II DR antibody. Transfus Med. 2003;13:141–148
  52. Sakagawa H, Miyazaki T, Fujihara M, et al. Generation of inflammatory cytokines and chemokines from peripheral blood mononuclear cells by HLA Class II antibody-containing plasma unit that was associated with severe nonhemolytic transfusion reactions. Transfusion. 2007;47:154–161
  53. Wakamoto S, Fujihara M, Sakagawa H, et al. Endothelial permeability is increased by the supernatant of peripheral blood mononuclear cells stimulated with HLA Class II antibody. Transfusion. 2008;48:2060–2080
  54. Silliman CC, Pitman J, Thurman G, et al. Neutrophil (PMN) priming agents develop in patients with transfusion related acute lung injury. Blood. 1992;80:261;(Suppl. 1), [abstr]
  55. Silliman CC, Thurman G, Ambruso DR. Stored blood components contain agents that prime the neutrophil NADPH oxidase through the platelet-activating-factor receptor. Vox Sang. 1992;63:133–136
  56. Silliman CC. The two-event model of transfusion-related acute lung injury. Crit Care Med. 2006;34:S124–S131(5 Suppl)
  57. Silliman CC, Johnson CA, Clay KL, et al. Compounds biologically similar to platelet activating factor are present in stored blood components. Lipids. 1993;28:415–418
  58. Silliman CC. Transfusion-related acute lung injury. Transfus Med Rev. 1999;13:177–186
  59. Zallen G, Moore EE, Ciesla DJ, et al. Stored red blood cells selectively activate human neutrophils to release IL-8 and secretory PLA2. Shock. 2000;13:29–33
  60. Biffl WL, Moore EE, Offner PJ, et al. Plasma from aged stored red blood cells delays neutrophil apoptosis and primes for cytotoxicity: Abrogation by poststorage washing but not prestorage leukoreduction. J Trauma. 2001;50:426–431
  61. Silliman CC, Curtis BR, Kopko PM, et al. Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microvascular endothelial cells in a two-event in-vitro model. Blood. 2007;109:1752–1755
  62. Kopko PM, Holland PV. Transfusion-related acute lung injury. Br J Haematol. 1999;105:322–329
  63. Toy P, Popovsky MA, Abraham E, et al. Transfusion-related acute lung injury: Definition and review. Crit Care Med. 2005;33:721–726
  64. Silliman CC, Clay KL, Thurman GW, et al. Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med. 1994;124:684–694
  65. Silliman CC, Dickey WO, Paterson AJ, et al. Analysis of the priming activity of lipids generated during routine storage of platelet concentrates. Transfusion. 1996;36:133–139
  66. de Jong M, Ray M, Crawford S, et al. Platelet and leukocyte activation in salvaged blood and the effect of its reinfusion on the circulating blood. Clin Orthop Relat Res. 2007;456:238–242
  67. Khan SY, Kelher MR, Heal , et al. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood. 2006;108:2455–2462
  68. Silliman CC, Bjornsen AJ, Tuder R, et al. Pre-storage leukoreduction of packed red blood cells inhibits tranfusion-related acute lung injury (TRALI) in an animal model. Blood. 2000;96:655a;[abstr]
  69. Silliman CC, Paterson AJ, Dickey WO, et al. The association of biologically active lipids with the development of transfusion-related acute lung injury: A retrospective study. Transfusion. 1997;37:719–726
  70. Medeiros BC, Kogela KE, Kaneab MA. Transfusion-related acute lung injury (TRALI) following platelet transfusion in a patient receiving high-dose interleukin-2 for treatment of metastatic renal cell carcinoma. Transfus Apheresis Sci. 2003;29:25–27
  71. Silliman CC, Boshkov LK, Mehdizadehkashi Z, et al. Transfusion-related acute lung injury: Epidemiology and a prospective analysis of etiologic factors. Blood. 2003;101:454–462
  72. Gajic O, Rana R, Winters JL, et al. Transfusion-related acute lung injury in the critically ill: Prospective nested case-control study. Am J Respir Crit Care Med. 2007;176:886–891
  73. Imoto S, Araki N, Shimada E, et al. Comparison of acute non-haemolytic transfusion reactions in female and male patients receiving female or male blood components. Transfus Med. 2007;17:455–465
  74. Kelher MR, Masuno T, Moore EE, et al. Plasma from stored PRBCs and MHC class I antibodies cause ALI in an two-event in-vivo model. Blood. 2008;113:2079–2087
  75. Bux J, Sachs UJ. The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol. 2007;136:788–799
  76. Kopko PM, Marshall CS, MacKenzie MR, et al. Transfusion-related acute lung injury: Report of a clinical look-back investigation. JAMA. 2002;287:1968–1971
  77. Lalezari P, Bernard GE. Identification of a specific leukocyte antigen: Another presumed example of 5b. Transfusion. 1965;45:135–142
  78. Nordhagen R, Conradi M, Drömtorp SM. Pulmonary reaction associated with transfusion of plasma containing anti-5b. Vox Sang. 1986;51:102–107
  79. Davoren A, Curtis BR, Shulman IA, et al. TRALI due to granulocyte-agglutinating human neutrophil antigen-3a (5b) alloantibodies in donor plasma: A report of 2 fatalities. Transfusion. 2003;43:641–645
  80. Muniz M, Sheldon S, Schuller RM, et al. Patient-specific transfusion-related acute lung injury. Vox Sang. 2008;94:70–73
  81. Wallis JP, Haynes S, Stark G, et al. Transfusion-related alloimmune neutropenia: An undescribed complication of blood transfusion. Lancet. 2002;360:1073–1074
  82. Leach M, Vora AJ, Jones DA, et al. Transfusion-related acute lung injury (TRALI) following autologous stem cell transplant for relapsed acute myloid leukemia: A case report and review of the literature. Transfus Med. 1998;8:333–337
  83. Sachs UJ, Bux J. TRALI after the transfusion of cross-match-positive granulocytes. Transfusion. 2003;43:1683–1686
  84. Wallis JP, Lubenko A, Wells AW, et al. Single hospital experience of TRALI. Transfusion. 2003;43:1053–1059
  85. Daveron A, Curtis B, Shulman IA, et al. TRALI due to granulocyte agglutinating human neutrophil antigen-3a (5b) alloantibodies in donor plasma; A report of 2 fatalities. Transfusion. 2003;43:641–645
  86. Leger R, Palm S, Wulf H, et al. Transfusion-related lung injury with leukopenic reaction caused by fresh frozen plasma containing anti-NB1. Anesthesiology. 1999;91:1529–1532
  87. Nishimura M, Takanashi M, Okazaki H, et al. Detection of anti-CD32 alloantibody in donor plasma implicated in development of transfusion-related acute lung injury. Cell Biochem Funct. 2007;25:179–183
  88. Fadeyi EA, Los Angeles MM, Wayne AS, et al. The transfusion of neutrophil-specific antibodies causes leukopenia and a broad spectrum of pulmonary reactions. Transfusion. 2007;47:545–550
  89. Sachs UJ, Chavakis T, Fung L, et al. Human alloantibody anti-Mart interferes with Mac-1–dependent leukocyte adhesion. Blood. 2004;104:727–734
  90. Hassell PJ, Minchinton RM, Stroncek D, et al: Anti-HNA-2a antibodies implicated in TRALI and ANN demonstrate serological variability and different epitope preferences. Transfusion [abstr] [In press]
  91. Bux J, Stroncek D. Human neutrophil antigens. Transfusion. 2002;42:1523;[letter]
  92. Fung L. The recipient side of TRALI—The role of patient neutrophils. Vox Sang. 2007;ISBT Science Series 2:135–140
  93. Bierling P, Bux J, Curtis B, et al. Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leukocyte antibody screening in the investigation and prevention of antibody-mediated TRALI. Vox Sang. 2008;96:266–269
  94. Bux J, Chapman J. Report on the Second International Granulocyte Serology Workshop. Transfusion. 1997;37:977–983
  95. Lucas G, Rogers S, De Haas M, et al. Report on the Fourth International Granulocyte Immunology Workshop: Progress toward quality assessment. Transfusion. 2002;42:462–468
  96. McCulloch J, Clay M, Press C, et al. Methods for detection of granulocyte antibodies. In: Granulocyte serology—A clinical and laboratory guide. Chicago: ASCP; 1988;p. 5–32
  97. Fung YL, Naidu A, Minchinton RM. Is it time to re-evaluate TRALI serology?. Transfusion. 2005;45:114A;[s3], [absrt]
  98. Lalezari P, Radel E. Neutrophil-specific antigens: Immunology and clinical significance. Semin Hematol. 1974;11:281–290
  99. Verheugt FW, dem Borne AE, Noord-Bokhorst JC, et al. Serological, immunochemical and immuoncytological properties of granulocyte antibodies. Vox Sang. 1978;35:394–403
  100. Zeevi A, Girnita A, Duquesnoy R. HLA antibody analysis: Sensitivity, specificity, and clinical significance in solid organ transplantation. Immunol Res. 2006;36:255–264
  101. Fuggle SV, Martin S. Tools for human leukocyte antigen antibody detection and their application to transplanting sensitized patients. Transplantation. 2008;86:384–390
  102. Cooling L. Transfusion-related acute lung injury. JAMA. 2002;288:315–316
  103. Toy P, Hollis-Perry KM, Jun J, et al. Recipients of blood from a donor with multiple HLA antibodies: A lookback study of transfusion-related acute lung injury. Transfusion. 2004;44:1683–1688
  104. Triulzi DJ, Kakaiya R, Schreiber G. Donor risk factors for white blood cell antibodies associated with transfusion-associated acute lung injury: REDS-II leukocyte antibody prevalence study (LAPS). Transfusion. 2007;47:563–564
  105. Fadeyi E, Adams S, Peterson B, et al. Analysis of a high-throughput HLA antibody screening assay for use with platelet donors. Transfusion. 2008;48:1174–1179
  106. O'Brien S, Lin Y, Bonacossa I, et al. HLA Class I and II antibodies in deferred blood donors at Canadian Blood Service. Transfusion. 2008;48:42A;[s2], [abstr]
  107. Rhamy J, Yarnell V, Susskind B. Evaluation of HLA screening methods for TRALI in random donors. Transfusion. 2008;48:41A;[s2], [abstr]
  108. Kao KJ, Scornik JC, Riley WJ, et al. Association between HLA phenotype and HLA concentration in plasma or platelets. Hum Immunol. 1988;21:115–124
  109. Jensen S, Jersild C, Grunnet N. Severe transfusion reaction to donor plasma containing HLA antibody. Vox Sang. 1990;59:62
  110. Kelher MR, Masuno T, Moore EE, et al. Plasma from stored packed red blood cells and MHC class I antibodies cause acute lung injury in a two-event in-vivo rat model. Blood. 2009;113:2079–2083
  111. Triulzi DJ, Kleinman S, Busch MP, et al. Relationship of HLA antibodies in blood donors to pregnancy and transfusion history. Transfusion. 2007;47:2A;[Suppl], [abstr]
  112. Triulzi DJ, Kleinman S, Kakaiya RM, et al. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: Implications for a transfusion related acute lung injury (TRALI) risk reduction strategy. Transfusion. 2009;[In press]
  113. Kopko PM, Popovsky MA, MacKenzie MR, et al. HLA class II antibodies in transfusion-related acute lung injury. Transfusion. 2001;41:1244–1248
  114. Kao GS, Wood IG, Dorfman DM, et al. Investigations into the role of anti-HLA class II antibodies in TRALI. Transfusion. 2003;43:185–191
  115. Gosselin EJ, Wardwell K, Rigby WF, et al. Induction of MHC class II on human polymorphonuclear neutrophils by granulocyte/macrophage colony-stimulating factor, IFN-gamma, and IL-3. J Immunol. 1993;151:1482–1490
  116. Nicolle AL, Chapman CE, Carter V, et al. Transfusion-related acute lung injury caused by two donors with anti-human leucocyte antigen class II antibodies: A look-back investigation. Transfus Med. 2004;14:225–230
  117. Stroncek DF, Fadeyi E, Adams S. Leukocyte antigen and antibody detection assays: Tools for assessing and preventing pulmonary transfusion reactions. Transfus Med Rev. 2007;21:273–286
  118. McCullough J, Press C, Clay M, et al. Implementation of granulocyte serology testing. Granulocyte serology—A clinical and laboratory guide. ASCP Press. 1988;145–154
  119. Wolter LS. An improved method for polymerase chain reaction typing of granulocyte antigens NA1 and NA2. Transfusion. 1995;35:885;[letter]
  120. Bux J, Stein EL, Bierling P, et al. Characterization of a new alloantigen (SH) on the human neutrophil Fc gamma receptor IIIb. Blood. 1997;89:1027–1034
  121. Clague HD, Fung YL, Minchinton RM. HNA-4a gene frequencies in an Australian population, determined by a new PCR method using sequence specific primers. Transfusion Medicine. 2003;13:149–152
  122. Sachs UJ, Reil A, Bauer C, et al. Genotyping of human neutrophil antigen-5a (Ond). Transfus Med. 2005;15:115–117
  123. Bux J, Becker F, Seeger W, et al. Transfusion-related acute lung injury due to HLA-A2-specific antibodies in recipient and NB1-specific antibodies in donor blood. Br J Haematol. 1996;93:707–713
  124. Fung YL, Fraser JF, Wood P, et al. The systemic inflammatory response syndrome induces functional changes and relative hypo-responsiveness in neutrophils. J Crit Care. 2008;23:542–549
  125. Bohmer RH, Trinkle LS, Staneck JL. Dose effects of LPS on neutrophils in a whole blood flow cytometric assay of phagocytosis and oxidative burst. Cytometry. 1992;13:525–531
  126. Botha AJ, Moore FA, Moore EE, et al. Postinjury neutrophil priming and activation: An early vulnerable window. Surgery. 1995;118:358–364
  127. Partrick DA, Moore EE, Fullerton DA, et al. Cardiopulmonary bypass renders patients at risk for multiple organ failure via early neutrophil priming and late neutrophil disability. J Surg Res. 1999;86:42–49
  128. Fung YL, Silliman CC, Minchinton RM, et al. Cardiopulmonary bypass induces enduring alterations to host neutrophil physiology: A single-centre longitudinal observational study. Shock. 2008;30:642–648
  129. Chapman CE, Williamson LM. National blood service TRALI reduction policies: Implementation and effect. Transfus Med Hemother. 2008;35:93–96
  130. Chapman CE, Stainsby D, Jones H, et al. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion. 2008;49:440–452
  131. Hume HA. TRALI: Moving toward prevention. Transfusion. 2009;49:402–405
  132. Maslanka K, Michur H, Zupanska B, et al. Leucocyte antibodies in blood donors and a look back on recipients of their blood components. Vox Sang. 2007;92:247–249
  133. Sachs UJ, Link E, Hofmann C, et al. Screening of multiparous women to avoid transfusion-related acute lung injury: A single centre experience. Transfus Med. 2008;18:348–354

 This work was supported by the Australian Red Cross Blood Service, the Bonfils Blood Center, and grants GM49222 from NIGMS and HL59355 from NHLBI, NIH (CCS).

PII: S0887-7963(09)00055-8

doi: 10.1016/j.tmrv.2009.06.001

Transfusion Medicine Reviews
Volume 23, Issue 4 , Pages 266-283 , October 2009

Article Tools

* Image Usage & Resolution